Table 5.

Number (%) of subjects reporting drug-related treatment-emergent adverse events

	Study 1		Study 2
	Test (N = 24)	Reference (N = 24)	Test (N = 23)	Reference (N = 24)
Participants with AEs	1 (4.2)	2 (8.3)	3 (13.0)	3 (12.5)
Number of AEs
Somnolence	1 (4.2)	0 (0.0)	2 (8.7)	2 (8.3)
Nausea	1 (4.2)	1 (4.2)	1 (4.3)	1 (4.2)
Feeling abnormal	0 (0.0)	1 (4.2)	0 (0.0)	0 (0.0)
Feeling hot	0 (0.0)	0 (0.0)	1 (4.3)	0 (0.0)